Mondaq Asia Pacific: Food, Drugs, Healthcare, Life Sciences
Clayton Utz
This article discusses how cybersecurity is an issue in health care since much of our information is being digitalised.
Sparke Helmore Lawyers
The issue provides information about legal issues and topics affecting health care providers, insurers and underwriters.
Sparke Helmore Lawyers
A number of states have seen significant developments affecting health care insurers and practitioners occur recently.
Sparke Helmore Lawyers
VMOs who treat patients on their own behalf are not considered employees, so do not have the same rights or protections.
Ropes & Gray LLP
Further legislative initiatives will be arranged if any parts of the draft policies contradict the current CFDA regulations.
Han Kun Law Offices
我国的药品流通市场长期以来处于市场竞争和行政管制并存的状态。政府在引导药品价格形成市场机制的同时,也在积极探索通过行政干预缓#
Han Kun Law Offices
药品技术合同的内容并不仅限于技术的开发或转让,往往还涉及到药品的临床试验申报、注册申请、报产审批、质量体系认证以及经销约定等A
Han Kun Law Offices
与药品技术合同定性问题容易引起争议一样,在药品技术合同纠纷中合同效力问题也经常成为案件的争议焦点。
Han Kun Law Offices
2017年2月13日,国家食品药品监督管理总局对外发布《食品安全欺诈行为查处办法(征求意见稿)》(以下简称"征求意见稿"),对产品欺诈、食品
Ropes & Gray LLP
China will launch further reforms in the pharmaceutical sector as part of the healthcare reform initiatives announced by the State Council in its February 9, 2017 Circular on Several Opinions Concerning Further Reforms of the Policies Governing Drug Production, Circulation and Usage (the "Circular No.13").
Han Kun Law Offices
Can foreign investors set up wholly-owned medical institutions in China? This is a question that clients constantly ask when entering the Chinese healthcare industry...
Jun He Law Office
Last year ushered in an abundance of new laws and regulations for the pharmaceutical industry in China. Various pharmaceutical policies, including national laws and regulations as well as local supporting policies such as the dual-invoice system, . . .
Han Kun Law Offices
As mentioned in Study on Foreign-Invested Medical Institutions (I), although China had at one time implemented a pilot program for establishing wholly foreign-owned hospitals, current policies prohibit full ownership.
Jun He Law Office
In early 2016, the Price Supervision and Anti-monopoly Bureau of China's National Development and Reform Commission issued the article "Key Issues on Price Supervision and Anti-monopoly in 2016" . . .
Han Kun Law Offices
With the continuous development of cloud computing and internet of things technology, the internet is further reshaping the healthcare industry.
Ropes & Gray LLP
The Revisions would standardize the conduct of drug studies in China, as well as strengthen the management of such studies.
Singh & Associates
The Uniform Code of Pharmaceuticals Marketing Practices, 2014 ("UCPMP Code") is a voluntary code issued by the Department Of Pharmaceuticals ("the Department") relating to marketing...
LexOrbis
Rich and varied biodiversity, accompanied by an extensive traditional and contemporary knowledge system makes India one of the most diverse nations in the world in this regard.
Khaitan & Co
Access to affordable and safe medicines is the cornerstone of a vibrant public health framework.
Duane Morris LLP
New Purchased/Referral Care (PRC) regulations give the Indian Health Service (I) , Tribal Organizations (T) and Urban Indian Organizations (U) the ability to cap payment rates...
Most Popular Recent Articles
Singh & Associates
The Uniform Code of Pharmaceuticals Marketing Practices, 2014 ("UCPMP Code") is a voluntary code issued by the Department Of Pharmaceuticals ("the Department") relating to marketing...
Corrs Chambers Westgarth
Blockchain is technology which allows a database or a ledger to be shared amongst a distributed network of computers.
Khurana and Khurana
Xtandi, the wonder drug for prostate cancer, was developed at UCLA, Los Angeles, by the innovation of NIH and Department of Defense grants.
Shelston IP
There is no certainty of PBS damages associated with a pharmaceutical patentee obtaining an interlocutory injunction.
Shelston IP
This decision removes what could have been a significant practical barrier to the Government proving its damages claim.
Khurana and Khurana
In the light of the recent order by Division Bench of Delhi High Court, this is an update to author's prior blog dated April 5 2017 pertaining to the legal dispute between Nuziveedu Seeds and Mosanto.
Khaitan & Co
Access to affordable and safe medicines is the cornerstone of a vibrant public health framework.
Ropes & Gray LLP
Further legislative initiatives will be arranged if any parts of the draft policies contradict the current CFDA regulations.
DibbsBarker
These changes reflect a new approach to health policy, with more collaboration between Government and key stakeholders.
S.S. Rana & Co. Advocates
In 2009, the Belgaum District Chemists and Druggists Association filed a complaint alleging that Abbott India Ltd. and Geno Pharmaceuticals had stopped the supply of essential medicines.
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter